Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

W Jack Schuler

Affiliations

  • Large Shareholder, Director at Accelerate Diagnostics Inc (AXDX), 2017-10-20
  • at Vermillion Inc. (VRML), 2017-09-05
  • Large Shareholder at Yield10 Bioscience Inc. (YTEN), 2017-08-02
  • Director at Stericycle Inc (SRCL), 2017-08-01
  • at Biolase Inc (BIOL), 2017-07-13
  • Large Shareholder, Director at Quidel Corp (QDEL), 2017-05-19
  • Large Shareholder at Neos Therapeutics Inc. (NEOS), 2017-02-17
  • Large Shareholder, Director at Hansen Medical Inc (HNSN), 2015-06-16
  • Large Shareholder at Gtx Inc (GTXI), 2014-03-21
  • at Medtronic Inc (MDT), 2013-06-27
  • Large Shareholder at Transition Therapeutics Inc. (TTHI), 2011-11-23
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaning Holdings Date Form 4
AXDX $20.14 45,000 Large Shareholder, Director 13,040,117 2017-10-18 Filing
AXDX $20.29 13,250 Large Shareholder, Director 12,995,117 2017-10-17 Filing
AXDX $20.07 59,922 Large Shareholder, Director 12,981,867 2017-10-16 Filing
AXDX $19.72 32,060 Large Shareholder, Director 12,954,005 2017-10-13 Filing
AXDX $18.81 29,240 Large Shareholder, Director 12,921,945 2017-10-13 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
GTXI $1.79 638,639 Large Shareholder 6,165,261 2014-03-21 Filing
GTXI $1.90 115,492 Large Shareholder 6,803,900 2014-03-20 Filing
GTXI $1.91 438,120 Large Shareholder 6,919,392 2014-03-19 Filing
SRCL $96.40 3,226 Director 147,967 2013-12-20 Filing
SRCL $96.40 3,226 Director 362,173 2013-12-20 Filing